目的采用针对人类Tudor—SN基因的RNA干扰(RNAi)技术建立Tudor—SN表达抑制的乳腺癌MDA—MB-231稳定细胞株。方法利用脂质体转染方法将pGenesil—shRNA—hTudor—SNI质粒转染进入MDA—MB-231细胞,经G418筛选出稳定株,通过RT—PCR检测Tudor—SN的mRNA水平,再以Western印迹技术鉴定Tudor—SN蛋白表达情况并计算蛋白表达抑制率。结果与对照组相比,以G418筛选的MDA—MB-231-Tudor—SNI稳定株Tudor—SN的mRNA水平降低(P〈0.01,n=3),蛋白表达水平明显下调(P〈0.01,n=3),蛋白表达抑制率达78.12%。结论成功筛选并鉴定人类Tudor—SN蛋白表达抑制MDA—MB-231稳定株,有助于深入研究Tudor—SN蛋白在乳腺癌中的作用。
Objective To transfect the constructed plasmid expressing down-regulation of Hu- man Tudor-SN Gene into MDA-MB-231 cells and screen the cell lines of stable interference human Tudor-SN gene. Methods Recombinant vector pGenesil-shRNA-hTudor-SNI was transfected into MDA-MB-231 cells using Lipofectamine-2000. The cell strains for stable and down-expression of Tudor-SN protein with the medium containing G418 sulfate were selected. The expression level of Tudor-SN was then detected by RT-PCR and western blotting assay. Results The hTudor-SN mRNA and protein expression levels in stable transfectant screened with G418 were down-regulated as com- pared to those in negative control group (P 〈0. 01, n = 3) . The inhibition rate of Tudor-SN protein expression was up to 78.12%. Conclusion The stable MDA-MB-231-Tudor-SNI cell lines were screened and examined successfully. The results are useful for research on the function of Tudor-SN protein on breast cancer.